Sphaeropsidin A in Liposomes: Reducing Toxicity and Fighting Candida auris
Author Information
Author(s): Annalisa Buonanno, Maria Michela Salvatore, Antonia Feola, Antonietta Siciliano, Rosa Bellavita, Lorenzo Emiliano Imbò, Marco Guida, Anna Andolfi, Rosario Nicoletti, Angela Maione, Annarita Falanga, Emilia Galdiero, René Csuk
Primary Institution: University of Naples Federico II
Hypothesis
Can Sphaeropsidin A, when encapsulated in liposomes, reduce its cytotoxicity while preserving antifungal activity against Candida auris?
Conclusion
Sphaeropsidin A and its liposomal form effectively inhibit Candida auris growth and biofilm formation without harming human cells.
Supporting Evidence
- SphA and SphA-L showed fungistatic activity against C. auris with MIC values of 35 μg/mL and 50 μg/mL, respectively.
- SphA-L significantly reduced the C. auris fungal load in Caenorhabditis elegans models.
- SphA-L exhibited low cytotoxicity on human cells compared to unencapsulated SphA.
Takeaway
This study shows that a natural compound called Sphaeropsidin A can fight a harmful fungus called Candida auris without hurting human cells when it's put inside tiny bubbles called liposomes.
Methodology
The study involved characterizing liposomes, testing antifungal activity against Candida auris, and evaluating cytotoxic effects on human cells and nematodes.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website